Neomorph Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 82

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $112M

  • Investors
  • 5

Neomorph General Information

Description

Operator of a biotechnology company intended to focus on the science of targeted protein degradation. The company uses molecular glue technology to discover and develop medicines against undruggable targets, enabling medical practitioners to prosecute a pipeline of projects through clinical development.

Contact Information

Website
www.neomorph.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5590 Morehouse Drive
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5590 Morehouse Drive
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neomorph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 17-Mar-2026 $112M Completed Clinical Trials - General
1. Early Stage VC (Series A) 22-Dec-2020 Completed Clinical Trials - General
To view Neomorph’s complete valuation and funding history, request access »

Neomorph Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Neomorph’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neomorph Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Neomorph Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236578-A2 Methods for the degradation of hif-1b (arnt) via a crbn/arnt/ small molecule ternary complex Pending 07-May-2025
WO-2026236571-A1 Substituted (piperidin-4-yl)-1,5-naphthyridine and (piperidin-4-yl)quinoline derivatives and uses thereof Pending 07-May-2025
WO-2026236558-A1 Substituted 3-(5-(4-hydroxypiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Pending 07-May-2025
WO-2026236567-A1 Substituted thienopyridyl and benzothiophenyl piperidine-2,6-dione derivatives and uses thereof Pending 07-May-2025
WO-2026030722-A1 Substituted imidazolyl dihydropyrimidine-2,4-dione and substituted imidazolyl piperidine-2,6-dione derivatives and uses thereof Pending 02-Aug-2024 C07D471/04
To view Neomorph’s complete patent history, request access »

Neomorph Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neomorph Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Binney Street Capital Corporate Venture Capital Minority
Longwood Fund Management Venture Capital Minority
Regeneron Ventures Corporate Venture Capital Minority
Deerfield Management Venture Capital Minority
To view Neomorph’s complete investors history, request access »

Ready to get started?

Request a free trial

Neomorph FAQs

  • When was Neomorph founded?

    Neomorph was founded in 2020.

  • Where is Neomorph headquartered?

    Neomorph is headquartered in San Diego, CA.

  • What is the size of Neomorph?

    Neomorph has 82 total employees.

  • What industry is Neomorph in?

    Neomorph’s primary industry is Drug Discovery.

  • Is Neomorph a private or public company?

    Neomorph is a Private company.

  • What is the current valuation of Neomorph?

    The current valuation of Neomorph is .

  • What is Neomorph’s current revenue?

    The current revenue for Neomorph is .

  • How much funding has Neomorph raised over time?

    Neomorph has raised $221M.

  • Who are Neomorph’s investors?

    Alexandria Venture Investments, Binney Street Capital, Longwood Fund Management, Regeneron Ventures, and Deerfield Management have invested in Neomorph.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process